Please login to the form below

Not currently logged in
Email:
Password:

pricing model

This page shows the latest pricing model news and features for those working in and with pharma, biotech and healthcare.

Duchenne UK and pharma partner pilot data-sharing HTA approach

Duchenne UK and pharma partner pilot data-sharing HTA approach

These delays are worsened for diseases as there is often limited evidence available to meet the requirements for access and pricing decisions.”. ... The hope is that the model could also be used for other rare diseases and provide greater certainty

Latest news

  • Post-Shkreli KaloBios pledges transparent pricing Post-Shkreli KaloBios pledges transparent pricing

    The new pricing model "will guide the company's strategy and operations", according to new CEO Cameron Durrant, who has pledged to price its Chagas disease treatment benznidazole on the basis ... Our new pricing model is a commitment to define and

  • UK pharma's contribution to NHS hits £1bn mark UK pharma's contribution to NHS hits £1bn mark

    The AAR was announced by Minister for Life Sciences George Freeman in November 2014 after it became apparent that plans to replace the PPRS with a value-based pricing model - along

  • National Audit Office agrees CDF is 'unsustainable' National Audit Office agrees CDF is 'unsustainable'

    The CDF was originally intended as a stop-gap while a new pricing mechanism for drugs was developed, but had to be extended when the government's attempts to replace the ... Pharmaceutical Price Regulation Scheme (PPRS) with a new value-based pricing

  • HIV deal in China helps GSK rebuild tattered reputation HIV deal in China helps GSK rebuild tattered reputation

    At the time the corruption scandal came to a head GSK said it intended to improve access to its medicines in China by adopting a more flexible pricing model.

  • Overcoming quantitative pricing limitations Overcoming quantitative pricing limitations

    Companies launching new treatments which don't have any therapeutic equivalent on the market often base their pricing strategy either on a 'value-added' pricing model, based on replacement or enhancement ... of current treatments in the same category,

More from news
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Brexit and Trump Brexit and Trump

    that we need to return to servicing a high-volume, low-cost model in consumer healthcare, and a parity pricing model in Rx.

  • Pharma deals in September 2015 Pharma deals in September 2015

    to pursue a “ robust” pricing model. ... Pharmaceuticals. He has also written a letter to employees to assuage their concerns over company's business model, potential exposure and the fall in the company's stock price (it fell

  • Interview: Richard Bergström, EFPIA Interview: Richard Bergström, EFPIA

    These are good examples of where legislation helps promote innovation, but unfortunately it's the access to markets, pricing and reimbursement that are deteriorating. ... I have worked very closely with the Swedish government to shape value-based-pricing.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... Pharma firms must identify products that will benefit from innovative pricing models, and then forge the types

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics